newsfilter
← Latest News
PR Newswire·

ESSA Securityholders Approve Acquisition by XenoTherapeutics

SOUTH SAN FRANCISCO, USA and VANCOUVER, Canada, Oct. 6, 2025 /PRNewswire/ - ESSA Pharma Inc. (NASDAQ: EPIX) ("ESSA" or the "Company") is pleased to...